WO1998022179A2 - Ultrasonically marked catheter for electrotherapy and system for use of the same - Google Patents

Ultrasonically marked catheter for electrotherapy and system for use of the same Download PDF

Info

Publication number
WO1998022179A2
WO1998022179A2 PCT/EP1997/006459 EP9706459W WO9822179A2 WO 1998022179 A2 WO1998022179 A2 WO 1998022179A2 EP 9706459 W EP9706459 W EP 9706459W WO 9822179 A2 WO9822179 A2 WO 9822179A2
Authority
WO
WIPO (PCT)
Prior art keywords
electrotherapy
catheter
outside
transducer
energy
Prior art date
Application number
PCT/EP1997/006459
Other languages
French (fr)
Other versions
WO1998022179A3 (en
Inventor
Branko Breyer
Bozidar Ferek-Petric
Achim Kitschmann
Wolfgang Geistert
Original Assignee
Sulzer Osypka Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sulzer Osypka Gmbh filed Critical Sulzer Osypka Gmbh
Priority to EP97952784A priority Critical patent/EP1039948A2/en
Priority to JP52321398A priority patent/JP2001505454A/en
Publication of WO1998022179A2 publication Critical patent/WO1998022179A2/en
Publication of WO1998022179A3 publication Critical patent/WO1998022179A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056Transvascular endocardial electrode systems
    • A61N1/0565Electrode heads
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1492Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/08Detecting organic movements or changes, e.g. tumours, cysts, swellings
    • A61B8/0833Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00106Sensing or detecting at the treatment site ultrasonic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577Ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00839Bioelectrical parameters, e.g. ECG, EEG
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37Surgical systems with images on a monitor during operation
    • A61B2090/378Surgical systems with images on a monitor during operation using ultrasound
    • A61B2090/3782Surgical systems with images on a monitor during operation using ultrasound transmitter or receiver in catheter or minimal invasive instrument
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3925Markers, e.g. radio-opaque or breast lesions markers ultrasonic
    • A61B2090/3929Active markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers

Definitions

  • This inventions relates to a field of medical technology, and in particular to technology of cardiac electrotherapy catheters guidable by ultrasound.
  • the specific application field is in the ablation of cardiac conductive paths and treatment of cardiac arhytmias.
  • This invention specifically improves ultrasonic marking and other measurements in connection with ablation catheters.
  • a particular problem in electrotherapy is the exact aiming of the delivering of therapeutic amounts of energy to defined points in organs such as heart.
  • the said energy is normally delivered using catheters.
  • the problem in visualization of flexible electrotherapy catheters indwelled into the human body is the fact that these devices are not in their entirety within the ultrasound scanning plane, so that without a specific solution one does not know which part of the catheter is imaged. This is a particular problem when the catheter is within the heart so that it moves and is therefore only discontinuously in the scanning plane.
  • a similar problem of visualization appears when the catheter is only partly visible because it passes through the areas where gasses in lungs or intestines partly prevent ultrasound penetration.
  • the problem of localization is particularly severe when an electrosurgery (cardiac ablation) electrode must be localized.
  • Tachycardia is the state of increased heart rate. Natural tachycardia occurs during physical exercise and emotional stress due to the tonus of the sympatic nervous system and increased concentration of circulating catecholamines. The most important property of the natural tachycardia is that it increases the heart minute volume (pumping rate) . Pathological tachycardia endangers the heart haemodynamics, i.e. the cardiac output decreases. Electrophysiology distinguishes two large groups of tachycardias: the supraventricular and the ventricular tachycardia as well as two groups of etiologies: ectopic foci and phenomenon of early excitation.
  • the principle of the therapy of tachycardia is to either depress the ectopic centres or interrupt the path of early excitation.
  • the first approach is always drug therapy.
  • every antiarhytmic drug is not effective with every patient.
  • the drugs can cause side effects that can be hazardous for the patient. Therefore one must take into consideration invasive procedures such as surgery of permanent implantation of an electrotherapy device.
  • the method of choice is the ablation of the conductive system in the heart. This is a semi invasive procedure. Transvenous ablation of the cardiac conductive system with a catheter is the less risky alternative to the surgical ablation for control of refractery supraventricular arhytmias.
  • Electrodes in the form of plates on one side of the catheter generate a directive electromagnetic field, but the problem of radial orientation of the catheter is thereby not solved. Marking is possible in other ways as described in the US patents nos. 5,161,536 and 5,425,370. The characterization of tissues is possible by the system for ablation described in the US patent 5,385,148.
  • a method for confirmation of the radial orientation is possible as described in our international PCT application no. PCT/EP94/04252 wherein the contact with the endocard and proximity fuse function have been described as well.
  • the basic principle is as follows: Near the position on the catheter which we want to localize (e.g. tip) a piezoelectric transducer is mounted which is connected to the outside electronic circuits using electrical conductors lied longitudinally along the catheter. The signals obtained on the said marker transducer can be used of generating a visible guiding mark on the echoscope screen as described in the said patents and patent applications.
  • the essential base of this invention consists in electrical connection of the outer electrode of a piezoelectric transducer to the source of the electrotherapy energy, e.g. for ablation of electrically conductive tissue in the heart.
  • the lead so far described as the lead for ultrasonic marking and electrotherapy can be used for electrodiagnostic procedures during electrotherapy (e.g. for the measurement of the electrocardiogram) .
  • Ultrasonically marked catheter for electrotherapy and system for use of the same comprises the piezoelectric transducer mounted onto a catheter and electrically connected to its proximal end with longitudinal conductors an outside localization circuit (transponder or passive system) an ultrasound diagnostic scanner and a source of energy for electrosurgery.
  • the said source of electrosurgery is connected to the outside electrode of the said piezoelectric transducer.
  • the electrodes of the said piezoelectric transducer are of appropriate thickness and conductivity that they can bear the ablation energy without damage.
  • the outside electrode is, depending on the ablation technology used, either in direct contact with the tissue or (for HF systems) covered with electrically insulating layer that does not impede the transmittal of high frequency waves for electrosurgery.
  • Fig. 1 is a block diagram of an integrated system for cardiac electrotherapy and ultrasonic guiding of the procedure.
  • Fig. 2 is a perspective illustrative drawing of the ultrasonically marked catheter for electrotherapy. In order to clarify the details, the catheter is shown much thicker compared to the length then in reality.
  • Fig. 3 is a cross sectional drawing of an axially symmetrical ultrasonically marked catheter for electrotherapy with the axis of its directivity characteristic approximately perpendicular to the catheter axis.
  • Fig. 4 is a drawing in two projections of an ultrasonically marked catheter for electrotherapy with the transducer and corresponding surface electrode in the form of plate.
  • the ultrasonically marked catheter for electrotherapy 1 is indwelled into the patient's body 100 for an electrosurgical procedure.
  • the transducer assembly 2 which essentially consists of a piezoelectric marker transducer and its electrodes.
  • the outer electrode serves to convey and deliver energy for the said medical procedure.
  • the transducer assembly 2 is connected to the outside electronic circuits by the way of electrical conductors laid along the catheter body 1.
  • the whole procedure is guided with the ultrasound scanner 41 using the probe 40 that scans the area 42 within the body.
  • Transponder 30 responds to each incoming ultrasound pulse from the probe 40 with a series of pulses, thus generating a visible mark on the echoscope screen 41.
  • Generator 200 When the transducer assembly 2 is maneuvered into the vicinity of the position for electrosurgery (by delivery of electrical energy) , Generator 200 is activated. This generator thus delivers the necessary energy via the transducer assembly 2. Circuit 210 prevents interference of instruments 200 and 30, i.e. isolates the generator 200 from transponder 30 when necessary.
  • Echoscope 41 is a normal medical ultrasound scanner normally used in ultrasound diagnostics, e.g. echocardiography. It usually functions at ultrasound frequencies of the order of magnitude 3 - 8 MHz.
  • the generator 200 is an electrosurgical generator normally used in medicine for ablation of conductive tissue in the heart or any other electrosurgical generator.
  • Circuit 210 is essentially a protection circuits (e.g. a diode protective circuit) that prevents the energy from generator 200 from damaging the transponder 30.
  • the said transducer assembly is mounted on some position along the catheter 1.
  • This piezoelectric transducer is connected via conductors 3 and 4 laid along the catheter 1 with connectors 5 and 6.
  • the position of the transducer assembly 2 along the catheter 1 is determined by the application need and can be anywhere between the proximal and distal end of the catheter 1. It is possible to use more than one transducer assembly of which each is connected with outside electrical circuits with its own conductors.
  • the transducer assembly can be divided into segments, e.g. incisions 7. On the outside of the transducer assembly there is the electrotherapy electrode or antenna.
  • FIG. 3 shows in more detail the transducer assembly 2 from figures 1 and 2.
  • This assembly consists of a piezoelectric transducer 21, outside electrode 22 that us at the same time used for electrotherapy, inside electrode 25 and conductors 3 and 4 which take the corresponding electrical signals.
  • Said outside and inside electrodes are connected to the said conductors with connections 33 and 34 respectively.
  • the connections 33 and 34 can be soldered, conductively glued or mechanical (by pressure) .
  • the said conductors 3 and 4 have on the proximal side connectors 5 and 6. Signals generated by piezoelectric transducer 21 are taken by the said conductors to connectors 5 and 6.
  • the electrical signals are taken to the said transducer by the said conductors.
  • a particular feature of the system is the outside electrode 22 connected with connection 34 via a conductor to connector 6, to which the energy for electrotherapy is brought from an appropriate generator (e.g. for high frequency cardiac ablation) .
  • the electrode has dimensions that enable conveying and delivering of electrical energy, current density in particular, needed for the electrosurgical procedure.
  • This embodiment has a response that is circularly symmetrical about the catheter axis, thus the axis of the directivity characteristic is essentially perpendicular to the same.
  • the cylindrical transducer consists of segments as shown in figure 2 (cut 7) , then one has to have conductors equivalent to conductors 3 and 4 along with their connectors for each of the said segments.
  • the whole transducer - antenna assembly can be covered with and insulating layer if the energy for electrosurgery is of such a nature that it does not require galvanic contact.
  • This layer can be made as a quarter wavelength matching layer for ultrasound when appropriate.
  • the insulation layer is not shown in figure 2, thus that form of the assembly is appropriate for the case when the ablation system is built to deliver energy galvanically.
  • an insulating layer 47 may be used.
  • the piezoelectric transducer 21 is built of piezoelectric material, e.g. piezoelectric ceramics with the resonant frequency in the range of the frequencies used by the ultrasound scanner used in ablation guidance.
  • a particular technological request in the present case, is that the material be chosen such that the electrosurgical energy flowing through its electrode does not damage it. This is reflected in request for a high Curie point and low dielectric loss.
  • the additional mechanical loading of the piezoelectric transducer by the mass of the thickened electrode lowers the mechanical resonance quality factor (Q) and thus broadens the frequency band and lower the sensitivity.
  • Optimum relation of the thickness and surface area is a matter of technological compromise for each combination of electrode material, piezoelectric material, amount of energy delivered and its type.
  • the second embodiment of the present invention is shown in figure 4.
  • a piezoelectric plate 41 is used for ultrasound reception and transmission.
  • Electrodes 42 and 45 are deposited on the sides of plate 41 and connected with connections 43 and 44 via longitudinal electrical conductors 3 and 4 to connectors 5 and 6.
  • Electrode 42 serves double purpose, i.e. for electrosurgery and as electrode of the piezoelectric marker transducer. It is possible to use more than one plate in the way of plate 41 and connect each of such plates to outside electrical circuits via their own conductors.
  • the insulating layer is here indicated with number 47. In this embodiment the ablation
  • Electrodes 42 energy can not be transferred galvanically, but in the form of high frequency electromagnetic fields with electrode 42 as antenna.
  • This embodiment costs less to manufacture and has an inherently narrower directivity characteristics compared to the embodiment shown in figure 3.

Abstract

Ultrasonically marked catheter for electrotherapy comprising a piezoelectric transducer (21) mounted onto a catheter and electrically connected to its proximal end with longitudinal conductors. The piezoelectric transducer electrodes are of appropriate thickness and conductivity for the ablation energy. The outside electrode (22) is either in direct contact with the tissue or, (for HF systems), covered with electrically insulating layer that does not impede the transmission of high frequency waves for electrosurgery. The same conductor within the catheter is used both for ultrasonic guidance purposes and for conveying energy. Ultrasonically marked catheter for electrotherapy improves the guidance of electrosurgical procedures due to the fact that the position of the ultrasonic marker transducer and electrotherapy member are at identical position. This invention represents an essential simplification and therefore reduction in price of the manufacture of the electrotherapy catheter with ultrasonic marking since one single element represents the therapy and the guiding system.

Description

Ultrasonically marked catheter for electrotherapy and system for use of the same
1. Field of the Invention
This inventions relates to a field of medical technology, and in particular to technology of cardiac electrotherapy catheters guidable by ultrasound. The specific application field is in the ablation of cardiac conductive paths and treatment of cardiac arhytmias. This invention specifically improves ultrasonic marking and other measurements in connection with ablation catheters.
2. Background and Prior Art
A particular problem in electrotherapy is the exact aiming of the delivering of therapeutic amounts of energy to defined points in organs such as heart. The said energy is normally delivered using catheters. The problem in visualization of flexible electrotherapy catheters indwelled into the human body is the fact that these devices are not in their entirety within the ultrasound scanning plane, so that without a specific solution one does not know which part of the catheter is imaged. This is a particular problem when the catheter is within the heart so that it moves and is therefore only discontinuously in the scanning plane. A similar problem of visualization appears when the catheter is only partly visible because it passes through the areas where gasses in lungs or intestines partly prevent ultrasound penetration. The problem of localization is particularly severe when an electrosurgery (cardiac ablation) electrode must be localized. The solution to this problem is particularly important when an electrotherapy aerial or electrode is marked in order to enable the guiding and control of electrotherapy procedures (e.g. cardiac ablation) using ultrasound echoscopy. In this case one must solve the problem of the most accurate localization of the electrode proper.
Tachycardia is the state of increased heart rate. Natural tachycardia occurs during physical exercise and emotional stress due to the tonus of the sympatic nervous system and increased concentration of circulating catecholamines. The most important property of the natural tachycardia is that it increases the heart minute volume (pumping rate) . Pathological tachycardia endangers the heart haemodynamics, i.e. the cardiac output decreases. Electrophysiology distinguishes two large groups of tachycardias: the supraventricular and the ventricular tachycardia as well as two groups of etiologies: ectopic foci and phenomenon of early excitation. The principle of the therapy of tachycardia is to either depress the ectopic centres or interrupt the path of early excitation. The first approach is always drug therapy. In spite of the recent advance of electropharmacology, every antiarhytmic drug is not effective with every patient. The drugs can cause side effects that can be hazardous for the patient. Therefore one must take into consideration invasive procedures such as surgery of permanent implantation of an electrotherapy device. The method of choice is the ablation of the conductive system in the heart. This is a semi invasive procedure. Transvenous ablation of the cardiac conductive system with a catheter is the less risky alternative to the surgical ablation for control of refractery supraventricular arhytmias. Some results have been achieved in the treatment of ventricular tachycardias as well. In order to achieve a control of the size of the lesion precise ablation energy sources have been introduced. One of the problems is the accurate positioning of the ablation electrode within the heart. As an alternative to the X ray imaging of the ablation catheter, ultrasonic imaging is agreeable in conjunction with the use of ultrasonically marked catheters and electrode catheters described in US patents nos. 4,697,595 and 4,706,681. These systems enable ultrasonic guidance of procedures as well as the exact localization of the tip or the electrode catheter. Position of the ablation electrode marked with an ultrasound transducer can exactly be determined. The same system, but with a slightly broader directivity characteristic of the ultrasound transducer has been described in US patent no. 5,076,278 using a curved transducer surface.
Electrodes in the form of plates on one side of the catheter generate a directive electromagnetic field, but the problem of radial orientation of the catheter is thereby not solved. Marking is possible in other ways as described in the US patents nos. 5,161,536 and 5,425,370. The characterization of tissues is possible by the system for ablation described in the US patent 5,385,148.
A method for confirmation of the radial orientation is possible as described in our international PCT application no. PCT/EP94/04252 wherein the contact with the endocard and proximity fuse function have been described as well. The basic principle is as follows: Near the position on the catheter which we want to localize (e.g. tip) a piezoelectric transducer is mounted which is connected to the outside electronic circuits using electrical conductors lied longitudinally along the catheter. The signals obtained on the said marker transducer can be used of generating a visible guiding mark on the echoscope screen as described in the said patents and patent applications.
All the described systems use the ultrasonic transducer as an element separate from the ablation electrode. This clearly complicated the mechanical and electrical design and construction of the ablation catheter.
These inventors are unaware of any system that integrates the source of electromagnetic field for ablation with the ultrasound receiver and transmitter used for ultrasonic marking. This integration is the technological problem solved with the present invention.
3. Summary of the invention
The essential base of this invention consists in electrical connection of the outer electrode of a piezoelectric transducer to the source of the electrotherapy energy, e.g. for ablation of electrically conductive tissue in the heart. Thereby the following results are achieved:
a) An essential increase of the accuracy of the ultrasonic marking of the electrotherapy (ablation) electrode. Contrary to the existing solutions mentioned in the paragraph "Background and prior art", here is the position of the marker transducer and the marked ablation electrode identical and not in the vicinity as solved in the said prior art. b) A reduction of the number of leads by at least one third, sometimes one half, since the same conductor is used to take the signal for ultrasonic marking and for the electrotherapy energy.
c) The lead so far described as the lead for ultrasonic marking and electrotherapy can be used for electrodiagnostic procedures during electrotherapy (e.g. for the measurement of the electrocardiogram) .
d) The manufacturing price is decreased since the production of the electrotherapy (ablation) electrode and the ultrasonic marker transducer is done in one step, which reduces time and manpower needed.
Ultrasonically marked catheter for electrotherapy and system for use of the same according to the present invention comprises the piezoelectric transducer mounted onto a catheter and electrically connected to its proximal end with longitudinal conductors an outside localization circuit (transponder or passive system) an ultrasound diagnostic scanner and a source of energy for electrosurgery. The said source of electrosurgery is connected to the outside electrode of the said piezoelectric transducer. The electrodes of the said piezoelectric transducer are of appropriate thickness and conductivity that they can bear the ablation energy without damage. The outside electrode is, depending on the ablation technology used, either in direct contact with the tissue or (for HF systems) covered with electrically insulating layer that does not impede the transmittal of high frequency waves for electrosurgery.
Thus, in addition to the improvement of the flexibility of the technological design and construction the manufacturing price is reduced. 4. Brief description of figures
Fig. 1 is a block diagram of an integrated system for cardiac electrotherapy and ultrasonic guiding of the procedure.
Fig. 2 is a perspective illustrative drawing of the ultrasonically marked catheter for electrotherapy. In order to clarify the details, the catheter is shown much thicker compared to the length then in reality.
Fig. 3 is a cross sectional drawing of an axially symmetrical ultrasonically marked catheter for electrotherapy with the axis of its directivity characteristic approximately perpendicular to the catheter axis.
Fig. 4 is a drawing in two projections of an ultrasonically marked catheter for electrotherapy with the transducer and corresponding surface electrode in the form of plate.
5. Description of embodiments
The system in which an ultrasonically marked catheter for electrotherapy functions is shown in figure 1.
The ultrasonically marked catheter for electrotherapy 1 is indwelled into the patient's body 100 for an electrosurgical procedure. On the catheter there is the transducer assembly 2 which essentially consists of a piezoelectric marker transducer and its electrodes. The outer electrode serves to convey and deliver energy for the said medical procedure. The transducer assembly 2 is connected to the outside electronic circuits by the way of electrical conductors laid along the catheter body 1. The whole procedure is guided with the ultrasound scanner 41 using the probe 40 that scans the area 42 within the body. Transponder 30 responds to each incoming ultrasound pulse from the probe 40 with a series of pulses, thus generating a visible mark on the echoscope screen 41. When the transducer assembly 2 is maneuvered into the vicinity of the position for electrosurgery (by delivery of electrical energy) , Generator 200 is activated. This generator thus delivers the necessary energy via the transducer assembly 2. Circuit 210 prevents interference of instruments 200 and 30, i.e. isolates the generator 200 from transponder 30 when necessary.
Echoscope 41 is a normal medical ultrasound scanner normally used in ultrasound diagnostics, e.g. echocardiography. It usually functions at ultrasound frequencies of the order of magnitude 3 - 8 MHz. The generator 200 is an electrosurgical generator normally used in medicine for ablation of conductive tissue in the heart or any other electrosurgical generator. Circuit 210 is essentially a protection circuits (e.g. a diode protective circuit) that prevents the energy from generator 200 from damaging the transponder 30.
According to figure 2 the said transducer assembly is mounted on some position along the catheter 1. This piezoelectric transducer is connected via conductors 3 and 4 laid along the catheter 1 with connectors 5 and 6. The position of the transducer assembly 2 along the catheter 1 is determined by the application need and can be anywhere between the proximal and distal end of the catheter 1. It is possible to use more than one transducer assembly of which each is connected with outside electrical circuits with its own conductors. The transducer assembly can be divided into segments, e.g. incisions 7. On the outside of the transducer assembly there is the electrotherapy electrode or antenna.
In the first embodiment which is shown in figure 3 is the piezoelectric transducer 21 of a cylindrical shape (ring) mounted on the catheter body 1. Figure 3 shows in more detail the transducer assembly 2 from figures 1 and 2. This assembly consists of a piezoelectric transducer 21, outside electrode 22 that us at the same time used for electrotherapy, inside electrode 25 and conductors 3 and 4 which take the corresponding electrical signals. Said outside and inside electrodes are connected to the said conductors with connections 33 and 34 respectively. The connections 33 and 34 can be soldered, conductively glued or mechanical (by pressure) . The said conductors 3 and 4 have on the proximal side connectors 5 and 6. Signals generated by piezoelectric transducer 21 are taken by the said conductors to connectors 5 and 6. Conversely, the electrical signals are taken to the said transducer by the said conductors. This enables the applications of various methods for guidance of medical procedures by ultrasonic echography. A particular feature of the system is the outside electrode 22 connected with connection 34 via a conductor to connector 6, to which the energy for electrotherapy is brought from an appropriate generator (e.g. for high frequency cardiac ablation) . The electrode has dimensions that enable conveying and delivering of electrical energy, current density in particular, needed for the electrosurgical procedure.
This embodiment has a response that is circularly symmetrical about the catheter axis, thus the axis of the directivity characteristic is essentially perpendicular to the same. If the cylindrical transducer consists of segments as shown in figure 2 (cut 7) , then one has to have conductors equivalent to conductors 3 and 4 along with their connectors for each of the said segments. The whole transducer - antenna assembly can be covered with and insulating layer if the energy for electrosurgery is of such a nature that it does not require galvanic contact. This layer can be made as a quarter wavelength matching layer for ultrasound when appropriate. The insulation layer is not shown in figure 2, thus that form of the assembly is appropriate for the case when the ablation system is built to deliver energy galvanically. When high frequency signal (electromagnetic wave) is used for ablation then an insulating layer 47 (figure 4) may be used.
The piezoelectric transducer 21 is built of piezoelectric material, e.g. piezoelectric ceramics with the resonant frequency in the range of the frequencies used by the ultrasound scanner used in ablation guidance. A particular technological request, in the present case, is that the material be chosen such that the electrosurgical energy flowing through its electrode does not damage it. This is reflected in request for a high Curie point and low dielectric loss. The additional mechanical loading of the piezoelectric transducer by the mass of the thickened electrode lowers the mechanical resonance quality factor (Q) and thus broadens the frequency band and lower the sensitivity. Optimum relation of the thickness and surface area is a matter of technological compromise for each combination of electrode material, piezoelectric material, amount of energy delivered and its type.
The second embodiment of the present invention is shown in figure 4. In this case a piezoelectric plate 41 is used for ultrasound reception and transmission. Electrodes 42 and 45 are deposited on the sides of plate 41 and connected with connections 43 and 44 via longitudinal electrical conductors 3 and 4 to connectors 5 and 6. Electrode 42 serves double purpose, i.e. for electrosurgery and as electrode of the piezoelectric marker transducer. It is possible to use more than one plate in the way of plate 41 and connect each of such plates to outside electrical circuits via their own conductors. The insulating layer is here indicated with number 47. In this embodiment the ablation
(electrosurgery) energy can not be transferred galvanically, but in the form of high frequency electromagnetic fields with electrode 42 as antenna.
This embodiment costs less to manufacture and has an inherently narrower directivity characteristics compared to the embodiment shown in figure 3.

Claims

Claims
1. Ultrasonically marked catheter for electrotherapy and system for use of the same characterized by comprising:
- an ultrasonically marked catheter that has piezoelectric transducer mounted on the body adjusted for the use in conjunction with an ultrasound scanner whose signal frequency spectra overlaps with the frequency spectrum of the said piezoelectric transducer having outside electrode thickened for cardiac ablation energy bearing and an electrotherapy/electrosurgery generator.
- where the said piezoelectric transducer is of a form that can be mounted onto the said catheter having the outside electrode of sufficient thickness and conductivity to convey the energy generated by the said electrotherapy/electrosurgery source without increase of its temperature above 90 degrees Celsius.
- where the said transducer's electrodes are connected to the outside electric circuits with electrical conductors running along the said catheter,
- where one of the said outside electronic circuits is an ultrasonic localization circuit in the form of a transponder or passive localization circuit, where an outside ultrasound scanner, as a part of the system is used for scanning of the body interior, - source of electrosurgery (ablation) energy for treatment of human tissues by delivering the energy through the said outside electrode of the said piezoelectric transducer.
2. Ultrasonically marked catheter for electrotherapy and system for use of the same according to claim 1, characterized by the transducer according to claim 1 is built as a whole or segmented ring (tube) .
3. Ultrasonically marked catheter for electrotherapy and system for use of the same according to claim 1, characterized by the transducer according to claim 1 is built as one or a multitude of plates.
4. Ultrasonically marked catheter for electrotherapy and system for use of the same according to claim 1, 2 and 3 characterized by the said transducer having electrodes on its outside and inside connected to the proximal side of the catheter from claim 1.
5. Ultrasonically marked catheter for electrotherapy and system for use of the same according to claim 1,
2 or 3 characterized by having the said outside electrode from claim 1 and 4 thickened and made maximally conductive.
6. Ultrasonically marked catheter for electrotherapy and system for use of the same according to claims
1, 2, 3, 4 or 5 characterized by having the outside localization electronic circuits from claim 1 and the electrosurgery (ablation) energy source connected to the same outside electrode of the piezoelectric transducer from claim 5. Ultrasonically marked catheter for electrotherapy and system for use of the same according to claims 1, 2, 3, 4 or 5 characterized by having a single lead leading from the said outside electrode from claim 1 and 5 to the outside localization circuit from claim 1 and outside electrosurgery circuit from claim 1.
PCT/EP1997/006459 1996-11-20 1997-11-19 Ultrasonically marked catheter for electrotherapy and system for use of the same WO1998022179A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP97952784A EP1039948A2 (en) 1996-11-20 1997-11-19 Ultrasonically marked catheter for electrotherapy and system for use of the same
JP52321398A JP2001505454A (en) 1996-11-20 1997-11-19 Ultrasound-labeled catheters for electrotherapy and systems using the catheters

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HRP960551A 1996-11-20
HR960551 1996-11-20

Publications (2)

Publication Number Publication Date
WO1998022179A2 true WO1998022179A2 (en) 1998-05-28
WO1998022179A3 WO1998022179A3 (en) 1998-07-16

Family

ID=10946495

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/006459 WO1998022179A2 (en) 1996-11-20 1997-11-19 Ultrasonically marked catheter for electrotherapy and system for use of the same

Country Status (3)

Country Link
EP (1) EP1039948A2 (en)
JP (1) JP2001505454A (en)
WO (1) WO1998022179A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005007228A1 (en) * 2003-07-18 2005-01-27 Branko Breyer Ultrasonically marked delivery system for left heart pacing lead
WO2012066446A1 (en) 2010-11-18 2012-05-24 Koninklijke Philips Electronics N.V. Sensing apparatus for sensing an object
WO2015155630A1 (en) * 2014-04-11 2015-10-15 Koninklijke Philips N.V. Needle with thin film piezoelectric sensors
US11357472B2 (en) 2015-12-15 2022-06-14 Koninklijke Philips N.V. Rotation determination in an ultrasound beam

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4697595A (en) 1984-07-24 1987-10-06 Telectronics N.V. Ultrasonically marked cardiac catheters
US4706681A (en) 1984-07-26 1987-11-17 Telectronics N.V. Cardiac ultrasonically marked leads and method for used same
US5076278A (en) 1990-10-15 1991-12-31 Catheter Technology Co. Annular ultrasonic transducers employing curved surfaces useful in catheter localization
US5161536A (en) 1991-03-22 1992-11-10 Catheter Technology Ultrasonic position indicating apparatus and methods
US5425370A (en) 1994-03-23 1995-06-20 Echocath, Inc. Method and apparatus for locating vibrating devices

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69417580T2 (en) * 1993-12-22 1999-12-16 Sulzer Osypka Gmbh ULTRASONICALLY MARKED INTRACARDIAL ABLATION CATHETER

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4697595A (en) 1984-07-24 1987-10-06 Telectronics N.V. Ultrasonically marked cardiac catheters
US4706681A (en) 1984-07-26 1987-11-17 Telectronics N.V. Cardiac ultrasonically marked leads and method for used same
US5076278A (en) 1990-10-15 1991-12-31 Catheter Technology Co. Annular ultrasonic transducers employing curved surfaces useful in catheter localization
US5161536A (en) 1991-03-22 1992-11-10 Catheter Technology Ultrasonic position indicating apparatus and methods
US5425370A (en) 1994-03-23 1995-06-20 Echocath, Inc. Method and apparatus for locating vibrating devices

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005007228A1 (en) * 2003-07-18 2005-01-27 Branko Breyer Ultrasonically marked delivery system for left heart pacing lead
WO2012066446A1 (en) 2010-11-18 2012-05-24 Koninklijke Philips Electronics N.V. Sensing apparatus for sensing an object
US9662170B2 (en) 2010-11-18 2017-05-30 Koninklijke Philips N.V. Sensing apparatus for sensing an object
WO2015155630A1 (en) * 2014-04-11 2015-10-15 Koninklijke Philips N.V. Needle with thin film piezoelectric sensors
US10952704B2 (en) 2014-04-11 2021-03-23 Koninklijke Philips N.V. Needle with thin film piezoelectric sensors
US11864948B2 (en) 2014-04-11 2024-01-09 Koninklijke Philips N.V. Needle with thin film sensors
US11357472B2 (en) 2015-12-15 2022-06-14 Koninklijke Philips N.V. Rotation determination in an ultrasound beam

Also Published As

Publication number Publication date
WO1998022179A3 (en) 1998-07-16
EP1039948A2 (en) 2000-10-04
JP2001505454A (en) 2001-04-24

Similar Documents

Publication Publication Date Title
US4706681A (en) Cardiac ultrasonically marked leads and method for used same
US5954649A (en) Catheter system having ultrasound locating capabilities
US6233477B1 (en) Catheter system having controllable ultrasound locating means
US5885219A (en) Interrogation device and method
US6246899B1 (en) Ultrasound locating system having ablation capabilities
US5800494A (en) Microwave ablation catheters having antennas with distal fire capabilities
US6673068B1 (en) Electrode arrangement for use in a medical instrument
US8425421B2 (en) Intracardiac catheters with image field electrodes
US6471696B1 (en) Microwave ablation instrument with a directional radiation pattern
US6259941B1 (en) Intravascular ultrasound locating system
US20040073110A1 (en) Transseptal access tissue thickness sensing dilator devices and methods for fabricating and using same
EP1669036A1 (en) Surgical microwave ablation assembly
WO2005055849A1 (en) Ultrasonically marked system for therapy delivery
EP1145686B1 (en) Ablation catheter with a directional hf irradiator
JP7416759B2 (en) Flexible circuit tip for split tip catheters
US20120271163A1 (en) Ultrasonic monitoring of implantable medical devices
WO1998022179A2 (en) Ultrasonically marked catheter for electrotherapy and system for use of the same
US11794004B2 (en) Electroporation with cooling
RU2777551C2 (en) Electrosurgical instrument for ablation
US11344221B2 (en) Flexible shielded position sensor
EP4134030A1 (en) A method for renal denervation
WO2020078758A1 (en) Energy transmission for an interventional device for medical interventions
CN116421299A (en) Coated microelectrodes
CN116549022A (en) Ultrasonic double-layer basket catheter
Breyer et al. Properties of ultrasonically marked leads

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1997952784

Country of ref document: EP

ENP Entry into the national phase in:

Ref country code: JP

Ref document number: 1998 523213

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 09308464

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1997952784

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997952784

Country of ref document: EP